GLP-1 Medication for Weight Loss in Coeur d’Alene, ID
GLP-1 medication for weight loss is capable of helping patients lose a degree of weight previously only possible through surgical procedures. GLP-1 medication for weight loss is available at Northwell Medical Solutions. Northwell Medical Solutions is here for your healthcare needs! Contact us for more information or schedule an appointment online. We are conveniently located at 1025 W Ironwood Dr Suite 3, Coeur d’Alene, ID 83814.
Table of Contents:
GLP-1 medication is a treatment previously used for diabetes that’s weight loss properties can lead to transformative results for obese patients. In addition to improving blood sugar control, a class of type 2 diabetes drugs can also stimulate weight loss. The drugs in this class are commonly known as glucagon-like peptide 1 (GLP-1) agonists.
A hormone called glucagon-like peptide 1 is mimicked by these drugs. A drug like this stimulates the production of insulin after someone eats to lower their blood sugar levels. Blood sugar levels are lowered by the extra insulin.
Type 2 diabetes can be controlled by lowering blood sugar levels. Weight loss is caused by GLP-1 drugs, but the mechanism is unclear. There is evidence that GLP-1s help curb hunger, according to doctors. Food is also delayed in moving from the stomach into the small intestine when these drugs are taken. Therefore, you may eat less because you feel full faster and longer.
Other major benefits of GLP-1s include controlling blood sugar and boosting weight loss. Researchers have found that some drugs in these groups may reduce the risk of heart disease, including heart failure, stroke, and kidney disease. These drugs have been found to lower blood pressure and cholesterol levels in people who take them. Although it is unclear whether the benefits are associated with the drug or with the weight loss.
In all but one case, GLP-1 drugs have to be taken by shot. As with any drug, there is the risk of side effects, some of them serious. It is often the case that common side effects will improve as you continue to take the drug.
There is an increasing problem of obesity around the world. Several chronic diseases such as diabetes are caused by obesity, through different mechanisms.
Chronic obesity-related diseases can be significantly improved by even small weight reductions. Obesity is currently treated primarily through lifestyle modifications. The available drugs and their side effects limit the effectiveness of pharmacotherapy, so bariatric surgery has often been the only effective treatment for morbid obesity, despite its merits and demerits. As a result, there is an increasing need to find effective and safe weight loss options for patients with substantial risks.
Satiety, eating behavior, and body weight can be regulated by GLP-1 agonist therapy through the incretin effect. There is no evidence that it can lead to weight loss in patients with type 2 diabetes. GLP-1 agonists increase insulin secretion while inhibiting glucagon only when glucose levels increase, so they can be used in obese, non-diabetic individuals without hypoglycemia concerns. Studies have shown that GLP-1 agonists cause significant and lasting weight loss in obese non-diabetic people without affecting blood pressure, HbA1c, or lipid profile adversely.
The percentage of U.S. adults who are overweight or obese exceeds 70 percent. In spite of these concerns, anti-obesity medications are only prescribed to 2 percent of eligible individuals due to concerns about safety and effectiveness, a lack of healthcare provider training in weight management, and a toxic stigma that portrays obesity as an inability to control your weight.
The introduction of GLP-1 medications for weight loss completely alters what is possible when it comes to medical weight loss management. More than half of the people treated with Wegovy lost more than 15 percent of their starting weight in clinical trials of Wegovy as an adjunct to lifestyle modification. For a 300-pound patient, that’s about 45 pounds – five times the weight loss found in traditional diets and exercise routines. The amount of weight loss achievable with GLP-1 medications was previously only achievable with drastic invasive surgery, and now GLP-1 patients can avoid many of the long-term negative health implications of obesity.
GLP-1 medication for weight loss is available at Northwell Medical Solutions. We are conveniently located at 1025 W Ironwood Dr Suite 3, Coeur d’Alene, ID 83814. For more information, contact us or request an appointment online. We serve patients from Coeur d’Alene ID, Hayden ID, Dalton Gardens ID, Fernan Lake Village ID, and Post Falls ID.